Literature DB >> 26152718

Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Blanca E Ruiz-Medina1, Jeremy A Ross1, Robert A Kirken2.   

Abstract

T, B, and natural killer cells are required for normal immune response and are regulated by cytokines such as IL-2. These cell signals are propagated following receptor-ligand engagement, controlling recruitment and activation of effector proteins. The IL-2 receptor β subunit (IL-2Rβ) serves in this capacity and is known to be phosphorylated. Tyrosine phosphorylation of the β chain has been studied extensively. However, the identification and putative regulatory roles for serine and threonine phosphorylation sites have yet to be fully characterized. Using LC-MS/MS and phosphospecific antibodies, a novel IL-2/IL-15 inducible IL-2Rβ phosphorylation site (Thr-450) was identified. IL-2 phosphokinetic analysis revealed that phosphorylation of IL-2Rβ Thr-450 is rapid (2.5 min), transient (peaks at 15 min), and protracted compared with receptor tyrosine phosphorylation and occurs in multiple cell types, including primary human lymphocytes. Pharmacological and siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulator, whereas purified protein phosphatase 1 (PP1), dephosphorylated Thr-450 in vitro. Reconstitution assays demonstrated that Thr-450 is important for regulating IL-2R complex formation, recruitment of JAK3, and activation of AKT and ERK1/2 and a transcriptionally active STAT5. These results provide the first evidence of the identification and functional characterization for threonine phosphorylation of an interleukin receptor.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  JAK; STAT transcription factor; cell signaling; interleukin 2; lymphocyte; protein kinase; protein phosphatase; receptor phosphorylation; serine/threonine; signal transduction

Mesh:

Substances:

Year:  2015        PMID: 26152718      PMCID: PMC4543656          DOI: 10.1074/jbc.M115.660654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Two discrete regions of interleukin-2 (IL2) receptor beta independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase.

Authors:  R A Kirken; M G Malabarba; J Xu; L DaSilva; R A Erwin; X Liu; L Hennighausen; H Rui; W L Farrar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

2.  Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics.

Authors:  Nerea Osinalde; Virginia Sanchez-Quiles; Vyacheslav Akimov; Barbara Guerra; Blagoy Blagoev; Irina Kratchmarova
Journal:  Proteomics       Date:  2014-09-30       Impact factor: 3.984

3.  Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.

Authors:  M G Malabarba; H Rui; H H Deutsch; J Chung; F S Kalthoff; W L Farrar; R A Kirken
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Authors:  Kevin C Conlon; Enrico Lugli; Hugh C Welles; Steven A Rosenberg; Antonio Tito Fojo; John C Morris; Thomas A Fleisher; Sigrid P Dubois; Liyanage P Perera; Donn M Stewart; Carolyn K Goldman; Bonita R Bryant; Jean M Decker; Jing Chen; Tat'Yana A Worthy; William D Figg; Cody J Peer; Michael C Sneller; H Clifford Lane; Jason L Yovandich; Stephen P Creekmore; Mario Roederer; Thomas A Waldmann
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

5.  Interleukin 2 induces a transient downregulation of protein phosphatase 1 and 2A activity in human T cells.

Authors:  J Brockdorff; M Nielsen; P Dobson; C Geisler; C Röpke; A Svejgaard; N Odum
Journal:  Tissue Antigens       Date:  1997-03

Review 6.  T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).

Authors:  P A Bunn; F M Foss
Journal:  J Cell Biochem Suppl       Date:  1996

7.  High-affinity interleukin 2 receptor alpha and beta chains are internalized and remain associated inside the cells after interleukin 2 endocytosis.

Authors:  V Duprez; M Ferrer; A Dautry-Varsat
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

8.  Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains.

Authors:  N Tanaka; H Asao; K Ohbo; N Ishii; T Takeshita; M Nakamura; H Sasaki; K Sugamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors:  S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

10.  Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase.

Authors:  R A Kirken; H Rui; M G Malabarba; W L Farrar
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

View more
  4 in total

1.  Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

Authors:  G Steven Martinez; Jeremy A Ross; Robert A Kirken
Journal:  Clin Cancer Drugs       Date:  2016

2.  Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions.

Authors:  Lukasz S Wylezinski; Jacek Hawiger
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

3.  Green barley mitigates cytotoxicity in human lymphocytes undergoing aggressive oxidative stress, via activation of both the Lyn/PI3K/Akt and MAPK/ERK pathways.

Authors:  Blanca E Ruiz-Medina; Dennise Lerma; Michael Hwang; Jeremy A Ross; Rachid Skouta; Renato J Aguilera; Robert A Kirken; Armando Varela-Ramirez; Elisa Robles-Escajeda
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

Review 4.  Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer.

Authors:  Arturo Valle-Mendiola; Adriana Gutiérrez-Hoya; María del Carmen Lagunas-Cruz; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  Mediators Inflamm       Date:  2016-05-12       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.